Expression of cyclooxygenase 2 in human malignant melanoma.
about
Relationship between the expression of cyclooxygenase 2 and MDR1/P-glycoprotein in invasive breast cancers and their prognostic significanceImmune-phenotypical markers for the differential diagnosis of melanocytic lesionsCurrent and future trials of targeted therapies in cutaneous melanomaDo altering in ornithine decarboxylase activity and gene expression contribute to antiproliferative properties of COX inhibitors?Upregulation of cyclooxygenase-2 is accompanied by increased expression of nuclear factor-kappa B and I kappa B kinase-alpha in human colorectal cancer epithelial cellsEffect of nimesulide on proliferation and apoptosis of human hepatoma SMMC-7721 cells.Aspirin and other NSAIDs as chemoprevention agents in melanomaDocosahexaenoic acid, G protein-coupled receptors, and melanoma: is G protein-coupled receptor 40 a potential therapeutic target?Contrast enhanced maximum intensity projection ultrasound imaging for assessing angiogenesis in murine glioma and breast tumor models: A comparative study.Coffee drinking and cutaneous melanoma risk in the NIH-AARP diet and health studyAspirin for the primary prevention of skin cancer: A meta-analysisNonsteroidal anti-inflammatory drugs and risk of melanoma.Detection of non-melanoma skin cancer by in vivo fluorescence imaging with fluorocoxib A.Biomarkers: the useful and the not so useful--an assessment of molecular prognostic markers for cutaneous melanomaVascular endothelial growth factor regulates melanoma cell adhesion and growth in the bone marrow microenvironment via tumor cyclooxygenase-2.Promoters with cancer cell-specific activity for melanoma gene therapy.Cyclooxygenase-Dependent Tumor Growth through Evasion of Immunity.Non-steroidal anti-inflammatory drugs, acetaminophen, and risk of skin cancer in the Nurses' Health Study.Role of nuclear factor-kappa B in melanoma.Simultaneous targeting of COX-2 and AKT using selenocoxib-1-GSH to inhibit melanomaA large cohort study of nonsteroidal anti-inflammatory drug use and melanoma incidence.Molecular mechanisms of flavonoids in melanin synthesis and the potential for the prevention and treatment of melanomaCyclooxygenase-2 and inducible nitric oxide synthase expression in thyroid neoplasms and their clinicopathological correlationCyclooxygenase-2 is associated with malignant phenotypes in human lung cancer.Differential expression of cyclooxygenase-2 in metastatic melanoma affects progression free survival.COX-2 expression positively correlates with PD-L1 expression in human melanoma cells.Reduction of COX-2 through modulating miR-124/SPHK1 axis contributes to the antimetastatic effect of alpinumisoflavone in melanoma.Targeting Melanoma with Cancer-Killing Viruses.Melanoma Chemoprevention: Current Status and Future Prospects.Regulation of viability, differentiation and death of human melanoma cells carrying neural stem cell biomarkers: a possibility for neural trans-differentiation.Autocrine secretion of 15d-PGJ2 mediates simvastatin-induced apoptotic burst in human metastatic melanoma cells.Molecular and Cellular Mechanisms of Antitumor Immune Response Activation by Dendritic Cells.RNAi-mediated knockdown of cyclooxygenase2 inhibits the growth, invasion and migration of SaOS2 human osteosarcoma cells: a case control study.Dual treatment with COX-2 inhibitor and sodium arsenite leads to induction of surface Fas Ligand expression and Fas-Ligand-mediated apoptosis in human melanoma cells.Discovery of potential biomarkers in human melanoma cells with different metastatic potential by metabolic and lipidomic profiling.Acetylsalicylic acid inhibits the growth of melanoma tumors via SOX2-dependent-PAF-R-independent signaling pathway.Cyclooxygenase 2 (COX2) and Peroxisome Proliferator-Activated Receptor Gamma (PPARG) Are Stage-Dependent Prognostic Markers of Malignant MelanomaEndogenous PGE(2) induces MCP-1 expression via EP4/p38 MAPK signaling in melanoma.
P2860
Q24813854-242DDE8F-8998-4A7F-A719-E5F7DBAF904DQ26776090-B34249D8-F57A-4E91-BC02-53968C1F2438Q27022355-96EDE0CA-2981-4854-A8AA-F94B7F73C693Q28195582-7A597C5E-592F-42FE-8120-152F18A429D4Q28384366-86218601-B42C-43B8-8B3F-8E6FE6527F86Q31066911-6AAD886B-C214-4DDC-8E9F-74BE7B68F755Q33725012-DAEE4A21-2795-47C4-AD23-73C5C242BBF6Q33756411-E9951381-D011-482E-BC14-23FFC82836C8Q34536116-220A0AFE-445B-4700-A196-5CB30D4E1D16Q35029323-AF6EC43E-B7DE-4A7C-91D1-DFBA6543C7B1Q35041988-37CCDF37-97BE-4E7D-A16A-B9947076B95DQ35101863-CA0D0BFA-DDA9-4729-A898-694E48085EF9Q35152553-C9AA8424-61AC-43E3-BBD3-EC6B275712F0Q35234354-61F5BCE2-9BC6-499C-9AFA-D11C90DA19B8Q35289963-D415E219-1447-4FDE-B032-6F606F25AB97Q35944371-11ADADF0-BE09-47BD-8418-D23369952935Q36134167-CC99A539-3A43-455F-A2FB-8205E28B55E1Q36157428-2877ACC7-F32B-4105-AC68-CDD258CFE34BQ36178379-65CA30EF-C70E-4CDD-884D-F958973DFD94Q36536476-066F4680-6E5E-4B13-BB24-A6629282227FQ36922601-1973D2AA-EB99-4922-9E04-EE392818647EQ36989431-8304A817-E0D3-4C73-B891-7AC62E1CED58Q37292064-A94BCE5D-CAF2-432C-AD6C-0A481EB81097Q37407198-E6108FAA-3692-4409-BEA1-68FFF49736F8Q37636757-62146C42-C086-490E-8757-FA433AC8B12DQ37663388-AD75661E-88BE-4422-B8BF-CA70C19E2878Q37732960-3FA4B451-42FB-4C2B-9518-8A3193D49483Q38676416-1C6EE649-C431-4F2A-BCF2-E6F5C1730601Q38745153-79D80CAB-8AC2-49C7-850D-58D548B16AC2Q38877894-C0A6C533-920C-46E2-913D-86178BE61A64Q38968834-8ACCB8BF-B14B-4FA9-811F-D89DC9D20075Q38994510-7E152CFF-C267-469E-A482-EE98B5C316A3Q39581230-305D2460-0BCC-4F3F-970A-9DD2AD51245DQ40314772-E2D75290-53CE-4D05-9F55-2CC4C6CE1051Q41458701-D8E478EC-02A3-4D90-ADC4-206B509C4296Q41472852-71B3E0E3-D3A5-4913-8FFE-4044DF6B9177Q42548468-E4DDA004-C3D1-415D-8F0F-3DFBB0643023Q43247091-E94B4B0C-2D8C-47EA-BD2E-99CA0EF2D80F
P2860
Expression of cyclooxygenase 2 in human malignant melanoma.
description
2001 nî lūn-bûn
@nan
2001 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2001 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2001年の論文
@ja
2001年論文
@yue
2001年論文
@zh-hant
2001年論文
@zh-hk
2001年論文
@zh-mo
2001年論文
@zh-tw
2001年论文
@wuu
name
Expression of cyclooxygenase 2 in human malignant melanoma.
@ast
Expression of cyclooxygenase 2 in human malignant melanoma.
@en
type
label
Expression of cyclooxygenase 2 in human malignant melanoma.
@ast
Expression of cyclooxygenase 2 in human malignant melanoma.
@en
prefLabel
Expression of cyclooxygenase 2 in human malignant melanoma.
@ast
Expression of cyclooxygenase 2 in human malignant melanoma.
@en
P2093
P1433
P1476
Expression of cyclooxygenase 2 in human malignant melanoma
@en
P2093
P304
P407
P577
2001-01-01T00:00:00Z